David - Interview 34  

David - Interview 34

Age at Interview: 56
Sex: Male
Background: David is a full-time student. He is single.

Brief outline:David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To close transcript boxes, click here
To print the interview’s text, click here
Male
David had expected to feel like a guinea pig, but actually felt it had been interesting and worthwhile. He was pleased to have a personal debrief with the specialist at the end of the trial.

 



At the end of the trial, how did you feel when it all stopped?
 
…I expected to feel like a guinea pig, but the doctor was particularly sensitive, and obviously had a genuine interest in asthma and chest conditions. And he sort of did a full debrief, really, and for example, I found through the test that apparently I had fluctuating levels of white blood plasma, which was slightly alarming, but I was glad that he’d pointed it out. He said that it may have been to do with the serum, or it may have been to do with a local infection that I’d had during the trial. But he didn’t have a complete answer to it, but he did take the trouble to discuss it with me and thank me for taking part. And I felt that - he made me feel in fact - that I’d contributed. So at the end I didn’t feel like a guinea pig, although I had expected to, yeah.
 
It may sound an odd question, but did you miss it once it finished?
 
Sort of, yeah, yes. Yes, I did, kind of, yeah, yes. I appreciated the relationship with this particular doctor. I found him very interesting and over the course of the months I sort of developed a proper relationship with him, and it’s always interesting to have access to a doctor’s knowledge when it’s not, you know, in a surgery. It’s sort of privileged information, really, which, yeah, I found very interesting, yeah.
 
Yeah, I had no misgivings after it ended. I did feel as if I’d contributed positively to something, and that it had been worthwhile, you know, yeah.

Clinical trials
   Support our work

Mail to a friend

Send